Evidence map›Paper›PMID 20466569›Full record

ArticleJournal of molecular graphics & modelling2010

Temperature-induced unfolding of epidermal growth factor (EGF): insight from molecular dynamics simulation.

Chunli Yan, Varun Pattani, James W Tunnell, Pengyu Ren

Abstract read
In one paragraph

Article in Journal of molecular graphics & modelling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chunli YanDepartment of Biomedical Engineering, University of Texas, Austin, TX 78712, USA.
Varun Pattani
James W Tunnell
Pengyu Ren

Funding

Metal nanoparticle-mediated diagnosis, targeting, and treatment of cancerR01CA132032 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI TUNNELL, JAMES W · 2008 to 2012
$1.6M
Computational Drug Discovery with Polarizable Potential Eneergy FunctionR01GM079686 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI REN, PENGYU · 2007 to 2011
$1.1M
NCI NIH HHS 5R01CA132032NCI NIH HHS R01 CA132032NIGMS NIH HHS (R01GM079686NIGMS NIH HHS R01 GM079686
6 · The paper itself

Abstract

Thermal disruption of protein structure and function is a potentially powerful therapeutic vehicle. With the emerging nanoparticle-targeting and femtosecond laser technology, it is possible to deliver heating locally to specific molecules. It is therefore important to understand how fast a protein can unfold or lose its function at high temperatures, such as near the water boiling point. In this study, the thermal damage of EGF was investigated by combining the replica exchange (136 replicas) and conventional molecular dynamics simulations. The REMD simulation was employed to rigorously explore the free-energy landscape of EGF unfolding. Interestingly, besides the native and unfolded states, we also observed a distinct molten globule (MG) state that retained substantial amount of native contacts. Based on the understanding that which the unfolding of EGF is a three-state process, we have examined the unfolding kinetics of EGF (N-->MG and MG-->D) with multiple 20-ns conventional MD simulations. The Arrhenius prefactors and activation energy barriers determined from the simulation are within the range of previously studied proteins. In contrast to the thermal damage of cells and tissues which take place on the time scale of seconds to hours at relatively low temperatures, the denaturation of proteins occur in nanoseconds when the temperature of heat bath approaches the boiling point.

Indexed as

Molecular Dynamics SimulationProtein UnfoldingTemperatureEpidermal Growth FactorErbB ReceptorsHumansHydrogenProtein Structure, SecondaryTime FactorsEpidermal Growth FactorErbB ReceptorsHydrogen

Identifiers

PMID20466569
PMCPMC2923262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.